|
2024
|
Invention
|
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload. The present ... |
|
|
Invention
|
Method to predict aml outcome. Jam-3Jam-3Jam-3-deficiency rewired the transcriptional program of ... |
|
|
Invention
|
Antisense oligonucleotides and their use for the treatment of cancer. In the present study, the i... |
|
|
Invention
|
Anti-nectin-4-antibodies and uses thereof.
The present invention relates to antibodies having sp... |
|
|
Invention
|
Biomarkers and methods of treatment of follicular lymphoma. Provided herein are methods and kits ... |
|
|
Invention
|
Tertiary amine compounds containing an alkyne or an azide moiety and their use. The present inven... |
|
|
Invention
|
Anti-mesothelin nanobodies, constructs and conjugates. The present invention relates to anti-meso... |
|
2023
|
Invention
|
Combination of a btn3a activating antibody, a bcl2 inhibitor and hypomethylating agent for use in... |
|
|
Invention
|
Humanized anti-nectin-4 antibodies. The present invention relates to humanized antibodies having ... |
|
|
Invention
|
Sigmar1 ligand for the treatment of pancreatic cancer. Here the inventors applied PDAC-derived CA... |
|
|
Invention
|
Sk2 inhibitor for the treatment of pancreatic cancer. Pancreatic Ductal Adenocarcinoma (PDAC) sti... |
|
|
Invention
|
Novel anti-nectin-4 antibodies and antibody-drug conjugates. The present invention relates to nov... |
|
|
Invention
|
Anti-mglur2 biparatopic nanobodies and uses thereof. The present invention relates to an anti-mGL... |
|
|
Invention
|
Novel formats of anti-cd28/spd-1 fusion constructs. The invention relates to a bispecific protein... |
|
2022
|
Invention
|
An ezh2 degrader or inhibitor for use in the treatment of resistant acute myeloid leukemia. The p... |
|
|
Invention
|
Anti-cd277 antibodies and uses thereof.
Described herein are anti-CD277 antibodies which: activa... |
|
|
Invention
|
New strategy targeting stroma/tumor cell crosstalk to treat a cancer. in vitroin vivoin vivo. Tar... |
|
|
Invention
|
Method for treating acute myeloid leukemia. The present invention relates the treatment of acute ... |
|
|
Invention
|
Butyrophilin (btn) 3a activating antibodies for use in methods for treating infectious disorders.... |
|
|
Invention
|
Anti-nectin-4-antibodies and uses thereof. The present invention relates to antibodies having spe... |
|
|
Invention
|
Anti-nectin-4 antibody exatecan conjugates. The present invention relates to an antibody-drug con... |
|
|
Invention
|
Anti-nectin-4 antibody amanitin conjugates. The present invention relates to an antibody-drug con... |
|
|
Invention
|
New method to evaluate pancreatic cancer prognosis. The present invention relates to the predicti... |
|
|
Invention
|
Nanoparticles comprising a core with a phenazine derivative and a shell with a nucleolipid and us... |
|
2021
|
Invention
|
Biomarkers for prognosing response to treatment against pancreatic ductal adenocarnicoma. The pre... |
|
|
Invention
|
Anti-cd25 antibodies.
Novel anti-human CD25 antibodies and their use for treating cancer and inf... |
|
|
Invention
|
Anti-cd25 antibodies.
Novel anti-human CD25 antibodies or antigen-binding fragments thereof and ... |
|
|
Invention
|
Anti-cd25 antibodies. The present invention relates to novel anti-human CD25 antibodies and their... |
|
|
Invention
|
Anti-gpc4 single domain antibodies. The present disclosure relates to anti-GPC4 single domain ant... |
|
|
Invention
|
New strategy for treating pancreatic cancer.
The present invention relates to the treatment of p... |
|
|
Invention
|
New strategy for treating pancreatic cancer. The present invention relates to the treatment of pa... |
|
|
Invention
|
New method to treat cutaneous t-cell lymphomas and tfh derived lymphomas.
The present invention ... |
|
|
Invention
|
New method to treat cutaneous t-cell lymphomas and tfh derived lymphomas. FHFHFH-derived lymphoma... |
|
|
Invention
|
Antibodies having specificity for btnl8 and uses thereof. The present invention relates to antago... |
|
2020
|
Invention
|
Targeting the nls region of nupr1 protein to treat cancer. The present invention relates to the t... |
|
|
Invention
|
Combination comprising nupr1 inhibitors to treat cancer. The present invention relates to the tre... |
|
|
Invention
|
Antisense oligonucleotides and thier use for the treatment of cancer.
The present invention conc... |
|
|
Invention
|
Antisense oligonucleotides and their use for the treatment of cancer. The present invention conce... |
|
|
Invention
|
Visual detection of pbd induced dna crosslinks.
The present invention relates to the field of on... |
|
|
Invention
|
Visual detection of pbd induced dna crosslinks. The present invention relates to the field of onc... |
|
|
Invention
|
Antibodies having specificity for nectin-4 and uses thereof. The present invention relates to ant... |
|
|
Invention
|
Method of treatment and pronostic of acute myeloid leukemia.
The present invention relates to th... |
|
|
Invention
|
Novel anti-cd25 antibodies.
Novel anti-CD25 antibodies and antigen-bind fragments thereof that d... |
|
|
Invention
|
Antibodies having specificity for btn2 and uses thereof. The present invention relates to antibod... |
|
2019
|
Invention
|
Btn3a binding proteins and uses thereof. It is disclosed anti-BTN3A activating antibody fragments... |
|
|
Invention
|
Nupr1 inhibition for treating cancer.
The present invention relates to the treatment of a tumor ... |
|
2017
|
Invention
|
Antibodies having specificity for btla and uses thereof.
The present invention relates to antibo... |
